Screener
Nurix Therapeutics, Inc. NRIX Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
| Line item | May 31,2026 | November 30,2025 |
|---|---|---|
| Accrued compensation | $13,449 | $21,541 |
| Accrued contract research and lab supplies | 15,300 | 14,952 |
| Accrued clinical | 10,774 | 13,260 |
| Accrued professional services | 2,193 | 1,944 |
| Accrued taxes | 247 | 1,059 |
| Other | 1,304 | 2,096 |
| Total accrued expenses and other current liabilities | $43,267 | $54,852 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Nurix Therapeutics, Inc.'s accrued expenses?
- Nurix Therapeutics, Inc. (NRIX) reported accrued expenses of $13.45M in Q1 2026.
- How has Nurix Therapeutics, Inc.'s accrued expenses changed year-over-year?
- Nurix Therapeutics, Inc.'s accrued expenses increased by 7.4% year-over-year, from $12.52M to $13.45M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s accrued expenses?
- Over 3 years (2022 to 2025), Nurix Therapeutics, Inc.'s accrued expenses has grown at a 17.8% compound annual growth rate (CAGR), from $13.16M to $21.54M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Nurix Therapeutics, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude